LOW-DENSITY-LIPOPROTEIN SUBCLASS PHENOTYPES AND FAMILIAL COMBINED HYPERLIPIDEMIA

[11] Crouse JR, Parks JS, Schey HM, Studies of low density lipoprotein molecular weight in human beings with coronary artery disease, J Lipid Res, 26, pp. 566-574, (1985)

[12] Campos H, Genest JJ, McNamara JR, Ordovas JM, Wilson PWF, Schaefer EJ, Low density lipoprotein particle size and coronary artery disease, Circulation, 82, 3, (1990)

[13] Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB, Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia, J Lipid Res, 24, pp. 147-155, (1983)

[14] Sniderman A, Teng B, Genest J, Cianflone K, Wacholder S, Kwiterovich P, Familial aggregation and early expression of hyperapobetalipoproteinemia, Am J Cardiol, 55, pp. 291-295, (1985)

[15] Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO, Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (B) lipoproteins, Proc Natl Acad Sci USA, 77, pp. 604-608, (1980)

[16] Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO, Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia, Proc Natl Acad Sci USA, 80, pp. 6662-6666, (1983)

[17] Rauh G, Schuster H, Muller B, Schewe S, Keller C, Wolfram G, Zollner N, Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia, Atherosclerosis, 83, pp. 81-87, (1990)

[18] Wojciechowski AP, Farrall M, Cullen P, Wilson TME, Bayliss JD, Farren B, Griffin BA, Caslake MJ, Packard CJ, Shepard J, Thakker R, Scott J, Familial combined hyperlipidemia linked to the apolipoprotein AI‐CIII‐AIV gene cluster on chromosome 11q23–24, Nature, 349, pp. 161-164, (1991)

[19] Hayden MR, Krik H, Clark C, Frohlich J, Rabkin S, McLeod R, Hewitt J, DNA polymorphisms in and around the apo AI‐CIII genes and genetic hyperlipidemias, Am J Hum Genet, 40, pp. 421-430, (1987)

[20] Babirak SP, Iverius P-H, Fujimoto WY, Brunzell JD, Detection and characterization of the heterozygote state for lipoprotein lipase deficiency, Arteriosclerosis, 9, pp. 326-334, (1989)

[11] Crouse JR, Parks JS, Schey HM, Studies of low density lipoprotein molecular weight in human beings with coronary artery disease, J Lipid Res, 26, pp. 566-574, (1985)

[12] Campos H, Genest JJ, McNamara JR, Ordovas JM, Wilson PWF, Schaefer EJ, Low density lipoprotein particle size and coronary artery disease, Circulation, 82, 3, (1990)

[13] Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB, Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia, J Lipid Res, 24, pp. 147-155, (1983)

[14] Sniderman A, Teng B, Genest J, Cianflone K, Wacholder S, Kwiterovich P, Familial aggregation and early expression of hyperapobetalipoproteinemia, Am J Cardiol, 55, pp. 291-295, (1985)

[15] Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO, Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (B) lipoproteins, Proc Natl Acad Sci USA, 77, pp. 604-608, (1980)

[16] Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO, Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia, Proc Natl Acad Sci USA, 80, pp. 6662-6666, (1983)

[17] Rauh G, Schuster H, Muller B, Schewe S, Keller C, Wolfram G, Zollner N, Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia, Atherosclerosis, 83, pp. 81-87, (1990)

[18] Wojciechowski AP, Farrall M, Cullen P, Wilson TME, Bayliss JD, Farren B, Griffin BA, Caslake MJ, Packard CJ, Shepard J, Thakker R, Scott J, Familial combined hyperlipidemia linked to the apolipoprotein AI‐CIII‐AIV gene cluster on chromosome 11q23–24, Nature, 349, pp. 161-164, (1991)

[19] Hayden MR, Krik H, Clark C, Frohlich J, Rabkin S, McLeod R, Hewitt J, DNA polymorphisms in and around the apo AI‐CIII genes and genetic hyperlipidemias, Am J Hum Genet, 40, pp. 421-430, (1987)

[20] Babirak SP, Iverius P-H, Fujimoto WY, Brunzell JD, Detection and characterization of the heterozygote state for lipoprotein lipase deficiency, Arteriosclerosis, 9, pp. 326-334, (1989)